REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 183 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $362,700 | -57.0% | 31,000 | -22.5% | 0.01% | -50.0% |
| Q1 2024 | $842,800 | -48.8% | 40,000 | -56.4% | 0.01% | -45.5% |
| Q4 2023 | $1,645,692 | +45.5% | 91,682 | +53.3% | 0.02% | 0.0% |
| Q1 2023 | $1,130,894 | -16.6% | 59,804 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $1,356,355 | -14.6% | 59,804 | -0.3% | 0.02% | 0.0% |
| Q3 2022 | $1,588,000 | -6.4% | 60,000 | -12.7% | 0.02% | -4.3% |
| Q2 2022 | $1,697,000 | -13.5% | 68,700 | +14.5% | 0.02% | +4.5% |
| Q4 2021 | $1,962,000 | -63.4% | 60,000 | -53.0% | 0.02% | -63.3% |
| Q3 2021 | $5,354,000 | +129.8% | 127,700 | +112.8% | 0.06% | +100.0% |
| Q2 2021 | $2,330,000 | +127.3% | 60,000 | +99.9% | 0.03% | +36.4% |
| Q1 2021 | $1,025,000 | -62.3% | 30,016 | -50.0% | 0.02% | -64.5% |
| Q4 2020 | $2,722,000 | -1.6% | 60,000 | -40.3% | 0.06% | -4.6% |
| Q3 2020 | $2,767,000 | – | 100,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
| Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
| ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
| Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
| Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
| RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
| WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
| HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
| Atom Investors LP | 36,487 | $901,000 | 0.39% |